Monoclonal Antibodies Market Trends – Industry Analysis, Share, Growth, Revenue, Top Key Players and Forecast 2028
Global Monoclonal Antibody Market value is expected to reach USD 282.89 Billion by 2028 with a CAGR of 10.1% over the forecast period.
Global Monoclonal Antibodies Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing prevalence of cancer & other chronic diseases, growing regulatory approvals & launch of therapies and increasing research collaborations for the development of robust drug pipeline are the major factors driving the growth of global monoclonal antibodies market Over the Forecast Period.
Scope of Global Monoclonal Antibody Market
A monoclonal antibody is an immune response made by cloning a remarkable white blood cell. All ensuing antibodies inferred this way trace back to a one of a kind parent cell. Monoclonal antibodies are utilized to develop and suppress the immune response in different medical situations and to treat different sicknesses like cardiovascular, cancer and cerebrovascular infections. This industry incorporates foundations that produce anti-cancer monoclonal antibodies to avoid metastasis by lessening cell expansion, neuropharmacological monoclonal antibodies, immunological monoclonal antibodies, anti-infective monoclonal antibodies (MAbs), and other MAbs for individuals and animals. By exposing white blood cells to a particular antigen, monoclonal antibodies can be created. Monoclonal antibodies are antibodies artificially created in laboratory.
Get Sample Copy of this Premium Report: https://brandessenceresearch.com/requestSample/PostId/1665
Monoclonal Antibodiesmarket report is segmented on the basis of test type, application and by regional & country level. Based upon test type, Monoclonal Antibodiesmarket is classified into predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, nutrigenomics and others. Based upon application, Monoclonal Antibodiesmarket is classified into cancer, genetic diseases, cardiovascular diseases and others.
Monoclonal AntibodiesMarket Key Players:
- Abbott Laboratories,
- Amgen Inc,
- AstraZeneca plc,
- Bayer AG,
- Eli Lilly,
- GlaxoSmithKline Plc,
- Johnson &Johnson,
- Merck&Co. Inc,
- Novartis AG,
- Pfizer Inc.,
- Sanofi S.A., F.
- Hoffmann-La Roche AG,
Monoclonal AntibodiesMarket Segmentation
- Autoimmune Disease
- Inflammatory Disease
- Infectious Disease
By End User:
- Research Institute
Monoclonal AntibodiesMarket Dynamics –
Rising incidence of blood cancer, genetic disorders, cardiovascular diseases and technological advancements and availability of new tests are some major factors driving the growth of the global Monoclonal Antibodiesmarket. According to the American Heart Association, about 2,200 Americans die of disorder every day, a mean of 1 death every 40 seconds. According to Leukemia Research Foundation, every three minutes, someone is diagnosed with blood cancer more than 175,000 new cases are expected in the United States in 2019. Additionally, Leukemia is diagnosed 10 times more often in adults than children. New cases of leukemia, lymphoma and myeloma are expected to account for 10 percent of the estimated 1,762,450 new cancer cases diagnosed in the US in 2019. According to American Cancer Society’s, estimates for leukemia in the United States for 2020 are about 60,530 new cases of leukemia and 23,100 deaths from leukemia in all ages as well as about 19,940 new cases of acute myeloid leukemia in adults only. Moreover, due to the advancement in cancer research, more patients with cancer are being successfully treated will propel growth of markets. However, high costs of Monoclonal Antibodiesand lack of skilled professionals will hamper the development of Monoclonal Antibodiesmarket. According to the National Institutes of Health, the cost of Monoclonal Antibodiescan range from under USD 100 to more than USD 2,000, depending on the nature and complexity of the test. However, innovations and advance development in genetic test and the increasing investment in cancer research is expected to boost the opportunity for the growth of Monoclonal Antibodiesmarket.
- U.S., Canada
- Germany, France, U.K., Italy, Spain, Sweden, Netherlands, Turkey, Switzerland, Belgium, Rest of Europe
- South_Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC
- Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America
Middle East and Africa
- Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA
- Human Microbiome Market to Grow USD 1544.9 Million by 2028 at a CAGR of 21.7% | Valuates Reports.
- Next Generation Sequencing (NGS) Market is expected to generate a revenue of USD 49.76 Billion by 2030, Globally, at 20.82% CAGR
- Automated Microbiology Market is expected to grow by US$ 10.69 billion during 2022-2030, accelerating at a CAGR of 8.8%, Growth Plus Reports
- Servier leverages Mission Bio’s Tapestri® Platform to uncover AML resistance mechanisms in pivotal TIBSOVO® (ivosidenib) clinical trial
- Molecular Diagnostics Market to Surpass $50.9 Billion in 2030.
- Clinical Oncology Next Generation Sequencing Global Market to Reach $680 Million by 2026.
- Statistics on Global Esoteric Testing Market Size & Share to Surpass USD 37917.67 Million by 2028, Exhibit a CAGR of 11.10% | Industry Trends, Value, Analysis & Forecast Report by Zion Market Research.
- Laser Technology Market worth $25.6 billion by 2027.
- With 20.1% CAGR, Gene Panel Market Size to Worth Around USD 8157.6 Million by 2028.
- Global Molecular Diagnostics Market to Surpass US$ 35,500.8 Million by 2030 – Coherent Market Insights
Brandessence Market Research & Consulting Pvt ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Mr. Vishal Sawant
Corporate Sales: +44-2038074155
Asia Office: +917447409162